EMvision Research Notes, page-823

Terrific opportunity here right now!

A few months ago, EMV stock price had to go up $4 to double your money and now that's halved to $2.

And that 'doubling' will happen quickly if the grant comes through and we get 'breakthrough' status with FDA.

Markets are fascinating places - all the folly that human beings are capable of seems to get doubled down when it comes to markets.

This lemming type selling is ludicrous when you place it in the context of the positive developments that have occurred over the past year - at both the industry and Company levels.

Not least the recent huge news that MSU's generate substantial 'clinical outcome' benefits - worth billions and the almost completion of the ASA's stroke telemedicine architecture - which will seek to exponentially increase those clinical outcome benefits across Australia and then the world - with just the novel imaging tech (being developed by EMV, Micro-X and Siemen) to be slotted in.

Not to mention the great team on board at Emvision now - both at the board and officer level.

Wish I had funds to take advantage of this anomalous slide. Happy days for those that can (albeit not necessarily immediately)